Patents by Inventor Amal Elsadig

Amal Elsadig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for targeted breast cancer therapies
    Patent number: 11865212
    Abstract: Systems and methods for producing liposomes, including control liposomes and immunoliposomes targeting breast cancer are provided. Systems and methods for treating breast cancer, using targeted immunoliposomes produced according to various methods are also disclosed herein. For example, trastuzumab-conjugated immunoliposomes may be used to deliver chemotherapeutic agents to breast cancer tissues for the treatment of breast cancer. Systems and methods for actuating liposomes using ultrasound are also disclosed, such as systems and methods for actuating trastuzumab-conjugated liposomes accumulated in breast cancer tissues for the treatment of breast cancer.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: January 9, 2024
    Assignee: American University of Sharjah
    Inventors: Ghaleb Husseini, Mohammad Al-Sayah, Amal Elsadig
  • SYSTEMS AND METHODS FOR TARGETED BREAST CANCER THERAPIES
    Publication number: 20210113465
    Abstract: Systems and methods for producing liposomes, including control liposomes and immunoliposomes targeting breast cancer are provided. Systems and methods for treating breast cancer, using targeted immunoliposomes produced according to various methods are also disclosed herein. For example, trastuzumab-conjugated immunoliposomes may be used to deliver chemotherapeutic agents to breast cancer tissues for the treatment of breast cancer. Systems and methods for actuating liposomes using ultrasound are also disclosed, such as systems and methods for actuating trastuzumab-conjugated liposomes accumulated in breast cancer tissues for the treatment of breast cancer.
    Type: Application
    Filed: December 11, 2020
    Publication date: April 22, 2021
    Inventors: Ghaleb Husseini, Mohammad Al-Sayah, Amal Elsadig
  • Systems and methods for targeted breast cancer therapies
    Patent number: 10864161
    Abstract: Systems and methods for producing liposomes, including control liposomes and immunoliposomes targeting breast cancer are provided. Systems and methods for treating breast cancer, using targeted immunoliposomes produced according to various methods are also disclosed herein. For example, trastuzumab-conjugated immunoliposomes may be used to deliver chemotherapeutic agents to breast cancer tissues for the treatment of breast cancer. Systems and methods for actuating liposomes using ultrasound are also disclosed, such as systems and methods for actuating trastuzumab-conjugated liposomes accumulated in breast cancer tissues for the treatment of breast cancer.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: December 15, 2020
    Assignee: American University of Sharjah
    Inventors: Ghaleb Husseini, Mohammad Al-Sayah, Amal Elsadig
  • SYSTEMS AND METHODS FOR TARGETED BREAST CANCER THERAPIES
    Publication number: 20190110989
    Abstract: Systems and methods for producing liposomes, including control liposomes and immunoliposomes targeting breast cancer are provided. Systems and methods for treating breast cancer, using targeted immunoliposomes produced according to various methods are also disclosed herein. For example, trastuzumab-conjugated immunoliposomes may be used to deliver chemotherapeutic agents to breast cancer tissues for the treatment of breast cancer. Systems and methods for actuating liposomes using ultrasound are also disclosed, such as systems and methods for actuating trastuzumab-conjugated liposomes accumulated in breast cancer tissues for the treatment of breast cancer.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 18, 2019
    Inventors: Ghaleb Husseini, Mohammad Al-Sayah, Amal Elsadig